Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- 最新申報
- 2026/8/13
2025 年第 2 季持倉
持倉截至 2025/6/30，2025/8/13 申報。只含多頭部位，變化是跟 2025 年第 1 季比股數。
- 持股檔數
- 77
- 較 2025 年第 1 季 −4
- 總值
- $6.76 億
- 較 2025 年第 1 季 +$3,751 萬 (+5.9%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| VRNAVerona Pharma plc | SPONSORED ADS | 610,000 | $5,769 萬 | 8.5% | −5,000−0.8% | 減碼 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 475,000 | $4,780 萬 | 7.1% | +335,000+239.3% | 加碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 1,100,000 | $3,443 萬 | 5.1% | −228,175−17.2% | 減碼 | 歷史 |
| ACLXArcellx, Inc. | COMMON STOCK | 495,000 | $3,260 萬 | 4.8% | −35,000−6.6% | 減碼 | 歷史 |
| BPMCBlueprint Medicines Corp | COM | 250,000 | $3,205 萬 | 4.7% | +250,000 | 新進 | 歷史 |
| NUVLNuvalent, Inc. | COM | 415,000 | $3,166 萬 | 4.7% | −45,000−9.8% | 減碼 | 歷史 |
| APGEApogee Therapeutics, Inc. | COM | 691,899 | $3,005 萬 | 4.4% | −459,300−39.9% | 減碼 | 歷史 |
| ALKSAlkermes plc. | SHS | 1,000,000 | $2,861 萬 | 4.2% | 00.0% | 不變 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 440,000 | $2,432 萬 | 3.6% | +40,000+10.0% | 加碼 | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 80,000 | $2,421 萬 | 3.6% | 00.0% | 不變 | 歷史 |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 1,400,000 | $2,346 萬 | 3.5% | 00.0% | 不變 | 歷史 |
| LXEOLexeo Therapeutics, Inc. | COM | 3,589,355 | $1,443 萬 | 2.1% | +2,108,474+142.4% | 加碼 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 970,000 | $1,436 萬 | 2.1% | −100,000−9.3% | 減碼 | 歷史 |
| ESTAEstablishment Labs Holdings Inc. | COM | 334,863 | $1,430 萬 | 2.1% | +54,863+19.6% | 加碼 | 歷史 |
| TRVITrevi Therapeutics, Inc. | COM | 2,534,058 | $1,386 萬 | 2.0% | +1,284,058+102.7% | 加碼 | 歷史 |
| WVEWave Life Sciences, Inc. | SHS | 2,000,308 | $1,300 萬 | 1.9% | +175,308+9.6% | 加碼 | 歷史 |
| VERAVera Therapeutics, Inc. | CL A | 545,000 | $1,284 萬 | 1.9% | +189,857+53.5% | 加碼 | 歷史 |
| MLYSMineralys Therapeutics, Inc. | COM | 900,000 | $1,218 萬 | 1.8% | −200,000−18.2% | 減碼 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 900,162 | $1,183 萬 | 1.7% | −646,500−41.8% | 減碼 | 歷史 |
| Karyopharm Therapeutics Inc.48576UAA4 | NOTE 3.000%10/1 | – | $1,162 萬 | 1.7% | – | – | – |
| NRIXNurix Therapeutics, Inc. | COM | 967,620 | $1,102 萬 | 1.6% | +156,951+19.4% | 加碼 | 歷史 |
| RZLTRezolute, Inc. | COM NEW | 2,200,000 | $981.2 萬 | 1.5% | +500,000+29.4% | 加碼 | 歷史 |
| VTYXVentyx Biosciences, Inc. | COM | 4,536,182 | $970.7 萬 | 1.4% | +4,536,182 | 新進 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM NEW | 606,678 | $908.2 萬 | 1.3% | +125,000+26.0% | 加碼 | 歷史 |
| ELVNEnliven Therapeutics, Inc. | COM | 400,000 | $802.4 萬 | 1.2% | +400,000 | 新進 | 歷史 |
| PRQRProQR Therapeutics N.V. | SHS EURO | 3,499,512 | $713.9 萬 | 1.1% | +215,000+6.5% | 加碼 | 歷史 |
| AKBAAkebia Therapeutics, Inc. | COM | 1,950,000 | $709.8 萬 | 1.0% | +450,000+30.0% | 加碼 | 歷史 |
| Omeros Corp682143AK8 | NOTE 9.500% 6/1 | – | $706.9 萬 | 1.0% | – | 新進 | – |
| INZYInozyme Pharma, Inc. | COM | 1,749,359 | $699.7 萬 | 1.0% | −2,118,351−54.8% | 減碼 | 歷史 |
| AUTLAutolus Therapeutics plc | SPON ADS | 3,045,000 | $694.3 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| ORKAOruka Therapeutics, Inc. | COM | 603,479 | $676.5 萬 | 1.0% | +58,117+10.7% | 加碼 | 歷史 |
| Travere Therapeutics, Inc.89422GAA5 | NOTE 2.250% 3/0 | – | $668.5 萬 | 1.0% | – | – | – |
| BBIOBridgeBio Pharma, Inc. | COM | 150,000 | $647.7 萬 | 1.0% | −150,000−50.0% | 減碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 390,000 | $545.2 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 50,000 | $522.0 萬 | 0.8% | −50,000−50.0% | 減碼 | 歷史 |
| ERASErasca, Inc. | COM | 4,085,787 | $518.9 萬 | 0.8% | +744,268+22.3% | 加碼 | 歷史 |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 275,000 | $498.0 萬 | 0.7% | −50,000−15.4% | 減碼 | 歷史 |
| CBIOCrescent Biopharma, Inc. | COM | 280,031 | $452.0 萬 | 0.7% | +280,031 | 新進 | 歷史 |
| ROIVRoivant Sciences Ltd. | SHS | 400,000 | $450.8 萬 | 0.7% | +250,000+166.7% | 加碼 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 152,252 | $437.9 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 125,000 | $406.4 萬 | 0.6% | +100,000+400.0% | 加碼 | 歷史 |
| FRNMFreenome, Inc. | CL A ORD SHS | 350,000 | $371.4 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| MRUSMerus N.V. | COM | 70,000 | $368.2 萬 | 0.5% | −251,962−78.3% | 減碼 | 歷史 |
| CATXPerspective Therapeutics, Inc. | COM NEW | 1,050,000 | $361.2 萬 | 0.5% | −1,174,196−52.8% | 減碼 | 歷史 |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 607,872 | $303.3 萬 | 0.4% | −49,282−7.5% | 減碼 | 歷史 |
| OACCUOaktree Acquisition Corp. III Life Sciences | UNIT 10/04/2029 | 250,000 | $265.5 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| JAZZJazz Pharmaceuticals plc | SHS USD | 25,000 | $265.3 萬 | 0.4% | +25,000 | 新進 | 歷史 |
| MNPRMonopar Therapeutics | COM NEW | 67,500 | $241.5 萬 | 0.4% | +5,500+8.9% | 加碼 | 歷史 |
| RAPPRapport Therapeutics, Inc. | COM | 199,643 | $227.0 萬 | 0.3% | +199,643 | 新進 | 歷史 |
| GERNGeron Corp | COM | 1,500,000 | $211.5 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| THRDThird Harmonic Bio, Inc. | COM | 370,000 | $200.9 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 263,817 | $198.7 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| NAMSWNewAmsterdam Pharma Co N.V. | *W EXP 11/22/202 | 245,000 | $196.0 萬 | 0.3% | +3,043+1.3% | 加碼 | 歷史 |
| QUREuniQure N.V. | SHS | 135,000 | $188.2 萬 | 0.3% | −265,000−66.3% | 減碼 | 歷史 |
| CLYMClimb Bio, Inc. | COM | 1,500,000 | $186.0 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| AVRAnteris Technologies Global Corp. | COM | 425,000 | $161.1 萬 | 0.2% | +35,000+9.0% | 加碼 | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 300,000 | $160.8 萬 | 0.2% | +300,000 | 新進 | 歷史 |
| NKTXNkarta, Inc. | COM | 800,000 | $132.8 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| MIRMMirum Pharmaceuticals, Inc. | COM | 24,692 | $125.7 萬 | 0.2% | −25,000−50.3% | 減碼 | 歷史 |
| SVRASavara Inc | COM | 500,000 | $114.0 萬 | 0.2% | +500,000 | 新進 | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 250,000 | $106.5 萬 | 0.2% | −75,000−23.1% | 減碼 | 歷史 |
| NXTCNextCure, Inc. | COM | 2,302,598 | $105.9 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| OKUROnKure Therapeutics, Inc. | COM CL A | 347,990 | $83.2 萬 | 0.1% | −46,169−11.7% | 減碼 | 歷史 |
| ABVXAbivax S.A. | SPONSORED ADS | 100,000 | $76.5 萬 | 0.1% | −100,000−50.0% | 減碼 | 歷史 |
| JBIOJade Biosciences, Inc. | COM NEW | 65,317 | $65.3 萬 | 0.1% | +65,317 | 新進 | 歷史 |
| STROSutro Biopharma, Inc. | COM | 752,722 | $53.7 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 200,000 | $46.2 萬 | 0.1% | +200,000 | 新進 | 歷史 |
| CNTXContext Therapeutics Inc. | COM | 518,025 | $33.9 萬 | 0.1% | −142,564−21.6% | 減碼 | 歷史 |
| ENGNenGene Therapeutics Inc. | COM | 77,000 | $28.0 萬 | <0.1% | +77,000 | 新進 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 200,000 | $27.8 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 223,335 | $23.5 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| OVIDOvid Therapeutics Inc. | COM | 667,516 | $22.0 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| RADXRadiopharm Theranostics Ltd | SPONSORED ADS | 35,635 | $16.6 萬 | <0.1% | −28,965−44.8% | 減碼 | 歷史 |
| ADGMAdagio Medical Holdings, Inc. | COM | 80,000 | $10.8 萬 | <0.1% | −133,235−62.5% | 減碼 | 歷史 |
| QTTBQ32 Bio Inc. | COM | 27,777 | $4.14 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| Rocket Pharmaceuticals, Inc.77313F114 | *W EXP 09/02/202 | 75,000 | $2,160 | <0.1% | 00.0% | 不變 | – |
| Immatics N.V.N44445117 | *W EXP 07/01/202 | 187,204 | $112 | <0.1% | 00.0% | 不變 | – |
選擇權（13 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| EXELExelixis, Inc. | COM | $1,983 萬 | $661.1 萬 |
| AMGNAmgen Inc | Stock | – | $1,117 萬 |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | – | $972.8 萬 |
| CAPRCapricor Therapeutics, Inc. | COM NEW | $173.8 萬 | – |
| NVAXNovavax Inc | COM NEW | – | $157.5 萬 |
| QUREuniQure N.V. | SHS | – | $139.4 萬 |
| OMEROmeros Corp | COM | $94.2 萬 | – |
| INMBInmune Bio, Inc. | COM | $81.8 萬 | – |
| ALTAltimmune, Inc. | COM NEW | – | $77.4 萬 |
| KPTIKaryopharm Therapeutics Inc. | COM NEW | – | $67.9 萬 |
| GALTGalectin Therapeutics Inc | COM NEW | $52.8 萬 | – |
| APGEApogee Therapeutics, Inc. | COM | $10.9 萬 | – |
| ABUSArbutus Biopharma Corp | COM | – | $2.87 萬 |
2025 年第 1 季之後清倉（16 檔）
2025 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2025 年第 1 季股數 | 2025 年第 1 季市值 | 2025 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| SPYSPDR S&P 500 ETF Trust | ETF | 30,000 | $1,678 萬 | 2.6% | 歷史 |
| Omeros Corp682143AG7 | NOTE 5.250% 2/1 | – | $1,428 萬 | 2.2% | – |
| IMVTImmunovant, Inc. | COM | 430,000 | $734.9 萬 | 1.2% | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 50,000 | $553.0 萬 | 0.9% | 歷史 |
| SLNOSoleno Therapeutics Inc | COM | 50,000 | $357.3 萬 | 0.6% | 歷史 |
| MAZEMaze Therapeutics, Inc. | COM | 250,000 | $275.3 萬 | 0.4% | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 100,000 | $273.7 萬 | 0.4% | 歷史 |
| JBIOJade Biosciences, Inc. | COM | 800,000 | $200.8 萬 | 0.3% | 歷史 |
| MBXMBX Biosciences, Inc. | COM | 175,000 | $129.2 萬 | 0.2% | 歷史 |
| ETNB89bio, Inc. | COM | 175,000 | $127.2 萬 | 0.2% | 歷史 |
| MGTXMeiraGTx Holdings plc | COM | 150,000 | $101.7 萬 | 0.2% | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 25,000 | $60.4 萬 | 0.1% | 歷史 |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 250,000 | $38.8 萬 | 0.1% | 歷史 |
| CMPXCompass Therapeutics, Inc. | COM | 130,807 | $24.9 萬 | <0.1% | 歷史 |
| OMEROmeros Corp | COM | 9,958 | $8.19 萬 | <0.1% | 歷史 |
| ALLKAllakos Inc. | COM | 250,000 | $5.69 萬 | <0.1% | 歷史 |